Ensysce Biosciences Inc
NASDAQ:ENSC
Income Statement
Earnings Waterfall
Ensysce Biosciences Inc
Revenue
|
2.2m
USD
|
Operating Expenses
|
-12.9m
USD
|
Operating Income
|
-10.7m
USD
|
Other Expenses
|
92.2k
USD
|
Net Income
|
-10.6m
USD
|
Income Statement
Ensysce Biosciences Inc
Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+176%
|
2
+174%
|
4
+87%
|
4
+10%
|
4
-6%
|
3
-25%
|
3
-8%
|
3
+8%
|
3
+10%
|
3
+5%
|
2
-29%
|
|
Operating Income | |||||||||||||||||||||||
Operating Expenses |
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(4)
|
(3)
|
(1)
|
(1)
|
(2)
|
(20)
|
(23)
|
(28)
|
(34)
|
(23)
|
(27)
|
(25)
|
(20)
|
(17)
|
(13)
|
|
Selling, General & Administrative |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(17)
|
(19)
|
(20)
|
(22)
|
(7)
|
(7)
|
(6)
|
(6)
|
(5)
|
(5)
|
|
Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(2)
|
(5)
|
(8)
|
(12)
|
(15)
|
(20)
|
(18)
|
(15)
|
(12)
|
(8)
|
|
Other Operating Expenses |
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(4)
|
(3)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(1)
N/A
|
(1)
-10%
|
(1)
-2%
|
(1)
-33%
|
(2)
-25%
|
(3)
-104%
|
(4)
-22%
|
(4)
+14%
|
(3)
+8%
|
(1)
+57%
|
(1)
+26%
|
(1)
-34%
|
(18)
-1 230%
|
(20)
-11%
|
(24)
-21%
|
(31)
-28%
|
(20)
+35%
|
(24)
-21%
|
(22)
+9%
|
(17)
+22%
|
(14)
+20%
|
(11)
+22%
|
|
Pre-Tax Income | |||||||||||||||||||||||
Interest Income Expense |
3
|
4
|
4
|
5
|
5
|
4
|
4
|
2
|
1
|
1
|
(0)
|
(1)
|
(2)
|
(1)
|
(0)
|
1
|
2
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(2)
|
(2)
|
(4)
|
(4)
|
(2)
|
(1)
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
5
|
5
|
5
|
5
|
2
|
3
|
(9)
|
(3)
|
(4)
|
(7)
|
4
|
(1)
|
(1)
|
1
|
0
|
|
Pre-Tax Income |
2
N/A
|
3
+53%
|
3
+17%
|
3
+4%
|
3
-6%
|
1
-70%
|
2
+96%
|
4
+147%
|
4
-18%
|
5
+25%
|
4
-15%
|
(0)
N/A
|
(17)
-4 336%
|
(29)
-68%
|
(29)
N/A
|
(36)
-24%
|
(29)
+20%
|
(24)
+16%
|
(25)
-5%
|
(20)
+22%
|
(13)
+36%
|
(11)
+16%
|
|
Net Income | |||||||||||||||||||||||
Tax Provision |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
1
|
2
|
3
|
3
|
2
|
0
|
1
|
4
|
3
|
4
|
4
|
0
|
(17)
|
(29)
|
(29)
|
(36)
|
(29)
|
(24)
|
(25)
|
(20)
|
(13)
|
(11)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
1
N/A
|
2
+54%
|
3
+18%
|
3
N/A
|
2
-4%
|
0
-85%
|
1
+273%
|
4
+159%
|
3
-8%
|
4
+31%
|
4
-14%
|
0
-96%
|
(17)
N/A
|
(30)
-74%
|
(31)
-2%
|
(38)
-23%
|
(30)
+19%
|
(25)
+17%
|
(26)
-2%
|
(20)
+22%
|
(13)
+36%
|
(11)
+16%
|
|
EPS (Diluted) |
46
N/A
|
70.66
+54%
|
83.33
+18%
|
83.33
N/A
|
80.33
-4%
|
12.33
-85%
|
46
+273%
|
119
+159%
|
110
-8%
|
143.66
+31%
|
52.99
-63%
|
2.28
-96%
|
-172.2
N/A
|
-373.62
-117%
|
-278.27
+26%
|
-269.07
+3%
|
-190.06
+29%
|
-139.38
+27%
|
-24.4
+82%
|
-8.74
+64%
|
-4.09
+53%
|
-4.69
-15%
|